Loading Events

Talk: David Redfern from GlaxoSmithKline on the development of vaccines

Have you ever wondered about how vaccines are developed, where perhaps the next major medical breakthrough will come from? Also just how much is spent on developing new vaccines?

Join us for a fascinating talk from David Redfern, Chief Strategy Officer of GlaxoSmithKline (GSK).
David will discuss GSK’s and the pharmaceutical industry’s current approach to the research and development of new medicines and vaccines, including specifically for covid, but also across oncology, infectious diseases such as HIV, neuroscience and other disease areas, and therefore where the significant medical advances are likely to be over the next decade.

David joined GSK in 1994. David was appointed Chairman of the Board of ViiV Healthcare Ltd in 2011 and is a Non-Executive Director of the Aspen Pharmacare Holdings Limited Board in 2015.
He has a BSc. degree from Bristol University and is a Chartered Accountant.
He has been a member of the Chartered Accountants Livery Company since 2018.


The talk starts at 6.30pm

Zoom link: https://us02web.zoom.us/j/21235250027?pwd=ZEZ3SWJUN3ovdXhXRE5NVkFzTWF6QT09

Meeting ID:
212 3525 0027
Passcode: 505497

Date

27 September

Time

6:30 pm - 8:00 pm

Share this event